← back to search

Ryan Kindle

Massachusetts Institute of Technology · US
Area of research
Artificial Intelligence · Infectious Diseases
Research interest
Research interests include Medicine, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Pediatrics, 2019-20 coronavirus outbreak, and Booster dose.
h-index
—
citations
643
works
4
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021
MMWR Morbidity and Mortality Weekly Report 2022cited by 99position: middledoi
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
MMWR Morbidity and Mortality Weekly Report 2021cited by 454position: middledoi
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021
The Journal of Infectious Diseases 2021cited by 23position: middledoi
Intensive Care Unit Telemedicine in the Era of Big Data, Artificial Intelligence, and Computer Clinical Decision Support Systems
Critical Care Clinics 2019cited by 67position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Omar Badawi · National Center for PTSD1 papers (2019–2019)Shawn Sturland · Massachusetts Institute of Technology1 papers (2019–2019)Leo Anthony Celi · Harvard University1 papers (2019–2019)